# Vaccine and Treatment Evaluation Units (VTEU)

> **NIH NIH UM1** · BAYLOR COLLEGE OF MEDICINE · 2020 · $5,921,655

## Abstract

ABSTRACT
This supplement request is for a Phase 3, randomized, stratified, observer-blind, placebo-
controlled study to evaluate the efficacy, safety and immunogenicity, of mRNA-1273 vaccine
compared to placebo in adults 18 years of age and older who have no known history of SARS-
CoV-2 infection but whose locations or circumstances put them at appreciable risk of acquiring
COVID-19 and/or SARS-CoV-2 infection. This request also relates to other COVID 19 activities.

## Key facts

- **NIH application ID:** 10200480
- **Project number:** 3UM1AI148575-01S2
- **Recipient organization:** BAYLOR COLLEGE OF MEDICINE
- **Principal Investigator:** HANA M EL SAHLY
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $5,921,655
- **Award type:** 3
- **Project period:** 2020-07-13 → 2022-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10200480

## Citation

> US National Institutes of Health, RePORTER application 10200480, Vaccine and Treatment Evaluation Units (VTEU) (3UM1AI148575-01S2). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10200480. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*